Cargando…

Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID)

The purpose of this study was to compare pretreatment volumetric modulated arc therapy (VMAT) quality assurance (QA) measurements and evaluate the multileaf collimator (MLC) error sensitivity of two detectors: the integral quality monitor (IQM) system (iRT systems IQM) and the electronic portal imag...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghafarian, Melissa, Price, Michael, Morales‐Paliza, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984480/
https://www.ncbi.nlm.nih.gov/pubmed/33596336
http://dx.doi.org/10.1002/acm2.13201
_version_ 1783668073502343168
author Ghafarian, Melissa
Price, Michael
Morales‐Paliza, Manuel
author_facet Ghafarian, Melissa
Price, Michael
Morales‐Paliza, Manuel
author_sort Ghafarian, Melissa
collection PubMed
description The purpose of this study was to compare pretreatment volumetric modulated arc therapy (VMAT) quality assurance (QA) measurements and evaluate the multileaf collimator (MLC) error sensitivity of two detectors: the integral quality monitor (IQM) system (iRT systems IQM) and the electronic portal imaging device (EPID) (Varian PortalVision aS1200). Pretreatment QA measurements were performed for 20 retrospective VMAT plans (53 arcs). A subset of ten plans (23 arcs) was used to investigate MLC error sensitivity of each device. Eight MLC error plans were created for each VMAT plan. The errors included systematic opening/closing (±0.25, ±0.50, ±0.75 mm) of the MLC and random positional errors (1 mm) for individual/groups of leaves. The IQM was evaluated using the percent error of the measured cumulative signal relative to the calculated signal. The EPID was evaluated using two methods: a novel percent error of the measured relative to the predicted cumulative signals, and gamma (γ) analysis (1%/1 mm, 2%/2 mm, 3%/3 mm and 3%/1 mm for Stereotactic Body Radiation Therapy plans). The average change in maximum dose obtained from dose‐volume histogram (DVH) data and change in detector signals for different systematic MLC shifts was also compared. Cumulative signal differences showed similar levels of agreement between measured and expected detector signals (IQM: 1.00 ± 0.55%; EPID: 1.22 ± 0.92%). Results from γ analysis lacked specificity. Only the 1%/1 mm criteria produced data with remarkable differences. A strong linear correlation was observed between IQM and EPID cumulative signal differences with MLC error magnitude (R = 0.99). Likewise, results indicate a strong correlation between the cumulative signal for both detectors and DVH dose (R(IQM) = 0.99; R(EPID) = 0.97). In conclusion, use of cumulative signal differences could be more useful for detecting errors in treatment delivery in EPID than γ analysis.
format Online
Article
Text
id pubmed-7984480
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79844802021-03-25 Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID) Ghafarian, Melissa Price, Michael Morales‐Paliza, Manuel J Appl Clin Med Phys Radiation Oncology Physics The purpose of this study was to compare pretreatment volumetric modulated arc therapy (VMAT) quality assurance (QA) measurements and evaluate the multileaf collimator (MLC) error sensitivity of two detectors: the integral quality monitor (IQM) system (iRT systems IQM) and the electronic portal imaging device (EPID) (Varian PortalVision aS1200). Pretreatment QA measurements were performed for 20 retrospective VMAT plans (53 arcs). A subset of ten plans (23 arcs) was used to investigate MLC error sensitivity of each device. Eight MLC error plans were created for each VMAT plan. The errors included systematic opening/closing (±0.25, ±0.50, ±0.75 mm) of the MLC and random positional errors (1 mm) for individual/groups of leaves. The IQM was evaluated using the percent error of the measured cumulative signal relative to the calculated signal. The EPID was evaluated using two methods: a novel percent error of the measured relative to the predicted cumulative signals, and gamma (γ) analysis (1%/1 mm, 2%/2 mm, 3%/3 mm and 3%/1 mm for Stereotactic Body Radiation Therapy plans). The average change in maximum dose obtained from dose‐volume histogram (DVH) data and change in detector signals for different systematic MLC shifts was also compared. Cumulative signal differences showed similar levels of agreement between measured and expected detector signals (IQM: 1.00 ± 0.55%; EPID: 1.22 ± 0.92%). Results from γ analysis lacked specificity. Only the 1%/1 mm criteria produced data with remarkable differences. A strong linear correlation was observed between IQM and EPID cumulative signal differences with MLC error magnitude (R = 0.99). Likewise, results indicate a strong correlation between the cumulative signal for both detectors and DVH dose (R(IQM) = 0.99; R(EPID) = 0.97). In conclusion, use of cumulative signal differences could be more useful for detecting errors in treatment delivery in EPID than γ analysis. John Wiley and Sons Inc. 2021-02-17 /pmc/articles/PMC7984480/ /pubmed/33596336 http://dx.doi.org/10.1002/acm2.13201 Text en © 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Ghafarian, Melissa
Price, Michael
Morales‐Paliza, Manuel
Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID)
title Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID)
title_full Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID)
title_fullStr Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID)
title_full_unstemmed Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID)
title_short Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID)
title_sort comparison of pretreatment vmat quality assurance with the integral quality monitor (iqm) and electronic portal imaging device (epid)
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984480/
https://www.ncbi.nlm.nih.gov/pubmed/33596336
http://dx.doi.org/10.1002/acm2.13201
work_keys_str_mv AT ghafarianmelissa comparisonofpretreatmentvmatqualityassurancewiththeintegralqualitymonitoriqmandelectronicportalimagingdeviceepid
AT pricemichael comparisonofpretreatmentvmatqualityassurancewiththeintegralqualitymonitoriqmandelectronicportalimagingdeviceepid
AT moralespalizamanuel comparisonofpretreatmentvmatqualityassurancewiththeintegralqualitymonitoriqmandelectronicportalimagingdeviceepid